IXC 5.71% 7.4¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-152

  1. 1,093 Posts.
    lightbulb Created with Sketch. 155
    my brain deals in market caps, and for a phase 3 indication I would have thought north of $200M as a starting point.

    that is a four times uplift from here for a start. I kind of think it will be there within 12-18 months but could easily run earlier as it really comes down to where the herd is looking (unfortunately).

    I have a decent position and want to add more, but waiting for some capital to free up elsewhere first... for me if I think there is a chance of going up five times within two years then it's a no brainer and I don't need to try and time it. as long as they don't go nuts at some point and double or triple the share registry at these low levels.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
0.004(5.71%)
Mkt cap ! $5.561M
Open High Low Value Volume
7.1¢ 7.5¢ 7.1¢ $4.091K 54.95K

Buyers (Bids)

No. Vol. Price($)
1 198734 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 29802 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.